Divis Laboratories Ltd - Share Price
DIVISLAB
Divis Laboratories LtdFinancials
Divis Laboratories LtdNews & Updates
Divis Laboratories to hold board meeting
Jan 23,2021 04:36 PM
On 6 February 2021
Pharma stocks under pressure in broad self off Jan 13,2021
Pharma stocks under pressure; Sun Pharma, Divis lab drag Jan 12,2021
Pharma stocks under pressure; Lupin offsets losses by surging 2% Jan 07,2021
Pharma stocks rally again to trade 0.50% higher; Auro Pharma, Lupin among leading gainers Jan 05,2021
Divis Laboratories Ltd up for fifth straight session Dec 31,2020
Meeting Type
Meeting Date
Resolution Type | Description Of Resolution | IiAS Recommendation |
---|
Peer Comparison
Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd | 572.30 | 47.88 | 137,973.76 | 724.81 | 0.70 | 3,207.24 | 106.10 |
Divis Laboratories Ltd | 3,521.95 | 53.52 | 94,092.68 | 513.30 | 0.45 | 1,713.78 | 313.47 |
Dr Reddys Laboratories Ltd | 4,985.65 | 34.09 | 83,711.25 | 481.00 | 0.50 | 3,333.60 | 979.38 |
Cipla Ltd | 815.75 | 29.06 | 65,166.04 | 745.64 | 0.49 | 3,711.03 | 233.61 |
Aurobindo Pharma Ltd | 963.10 | 20.34 | 54,120.22 | 801.54 | 0.32 | 4,425.43 | 246.88 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Divis Laboratories LtdSummary & Reports
Divis Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies. Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. The company has four ... More
Registered Office
1-72-23(P)/DIVIS/303 Divi Towe,Cyber Hills Gachibowli,Hyderabad, Telangana,500032
Tell. : +91-40-23786300/23786352/400
Website : http://www.divislaboratories.com
Email : mail@divislabs.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com
Reports by divis-laboratories-ltd-share-price
Latest Release by divis-laboratories-ltd-share-price
Result Express
Jan 25, 2021 10:39 AM
The company’s standalone revenue stood at Rs1,342.92cr, up 29.39% yoy and 4.51% qoq.
Shareholding Snapshot
Corporate Action
Purpose
Board Meeting
Exp. Date
07 Nov 2020
Annc. Date
27 Oct 2020
DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More
Purpose
AGM
Exp. Date
14 Sep 2020
Annc. Date
17 Aug 2020
AGM 14/09/2020As already informed vide our letter dated 17 August, 2020, the 30th Annual General Mee... More
Purpose
Board Meeting
Exp. Date
08 Aug 2020
Annc. Date
29 Jul 2020
DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More